CODX – Co-Diagnostics, Inc.
CODX — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
2.97
Margin Of Safety %
Put/Call OI Ratio
0.09
EPS Next Q Diff
-3.59
EPS Last/This Y
36.5
EPS This/Next Y
-11.45
Price
1.75
Target Price
45
Analyst Recom
3
Performance Q
-75.78
Upside
-57,560.0%
Beta
1.38
Ticker: CODX
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-02-27 | CODX | 2.3 | N/A | N/A | 0 |
| 2026-03-02 | CODX | 2.3 | N/A | N/A | 0 |
| 2026-03-03 | CODX | 2.23 | N/A | N/A | 0 |
| 2026-03-04 | CODX | 2.33 | N/A | N/A | 0 |
| 2026-03-05 | CODX | 2.15 | N/A | N/A | 0 |
| 2026-03-06 | CODX | 2.11 | N/A | N/A | 0 |
| 2026-03-09 | CODX | 2.18 | N/A | N/A | 0 |
| 2026-03-10 | CODX | 3.983 | N/A | N/A | 0 |
| 2026-03-11 | CODX | 3.23 | N/A | N/A | 0 |
| 2026-03-12 | CODX | 2.75 | 0.09 | 11.00 | 2433 |
| 2026-03-13 | CODX | 2.63 | 0.09 | 11.00 | 2433 |
| 2026-03-17 | CODX | 2.28 | 0.09 | 0.10 | 2432 |
| 2026-03-18 | CODX | 2.29 | 0.09 | 0.10 | 2432 |
| 2026-03-19 | CODX | 2.665 | 0.09 | 0.10 | 2432 |
| 2026-03-20 | CODX | 2.63 | 0.09 | 0.00 | 2429 |
| 2026-03-23 | CODX | 2.23 | 0.09 | 0.00 | 2429 |
| 2026-03-24 | CODX | 2.23 | 0.09 | 0.00 | 2429 |
| 2026-03-25 | CODX | 2.01 | 0.09 | 0.00 | 2429 |
| 2026-03-26 | CODX | 2.03 | 0.09 | 0.00 | 2429 |
| 2026-03-27 | CODX | 1.76 | 0.09 | 0.00 | 2429 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-02-27 | CODX | 2.32 | 68.2 | - | -0.70 |
| 2026-03-02 | CODX | 2.30 | 68.2 | - | -0.70 |
| 2026-03-03 | CODX | 2.30 | 68.2 | - | -0.70 |
| 2026-03-04 | CODX | 2.23 | 68.2 | - | -0.70 |
| 2026-03-05 | CODX | 2.33 | 68.2 | - | -0.70 |
| 2026-03-06 | CODX | 2.33 | 68.2 | - | -0.70 |
| 2026-03-09 | CODX | 2.11 | 68.2 | - | -0.70 |
| 2026-03-10 | CODX | 2.18 | 68.2 | - | -0.70 |
| 2026-03-11 | CODX | 3.21 | 68.2 | - | -0.70 |
| 2026-03-12 | CODX | 2.81 | 68.2 | - | -0.70 |
| 2026-03-13 | CODX | 2.80 | 68.2 | - | -0.70 |
| 2026-03-17 | CODX | 2.24 | 68.2 | - | -0.70 |
| 2026-03-18 | CODX | 2.29 | 68.2 | - | -0.70 |
| 2026-03-19 | CODX | 2.62 | 68.2 | - | -0.70 |
| 2026-03-20 | CODX | 2.60 | 68.2 | - | -0.70 |
| 2026-03-23 | CODX | 2.24 | 68.2 | - | -0.70 |
| 2026-03-24 | CODX | 2.23 | 68.2 | - | -0.70 |
| 2026-03-25 | CODX | 2.02 | 68.2 | - | -0.70 |
| 2026-03-26 | CODX | 2.02 | 68.2 | - | -0.70 |
| 2026-03-27 | CODX | 1.75 | 68.2 | - | -0.70 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-03-11 | CODX | 0 | 0 | 0.33 |
| 2026-03-12 | CODX | 0.00 | 0 | 0.33 |
| 2026-03-13 | CODX | 0.00 | 0 | 0.33 |
| 2026-03-20 | CODX | 0 | 0 | 0 |
| 2026-03-23 | CODX | 0.00 | -8.73 | 0 |
| 2026-03-24 | CODX | 0.00 | -8.73 | 0 |
| 2026-03-25 | CODX | 0.00 | -8.73 | 2.97 |
| 2026-03-26 | CODX | 0.00 | -8.73 | 2.97 |
| 2026-03-27 | CODX | 0.00 | -8.73 | 2.97 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.16
Avg. EPS Est. Current Quarter
-0.12
Avg. EPS Est. Next Quarter
-3.75
Insider Transactions
Institutional Transactions
-8.73
Beta
1.38
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
26
Growth Score
28
Sentiment Score
2
Actual DrawDown %
99.5
Max Drawdown 5-Year %
-99.4
Target Price
45
P/E
Forward P/E
PEG
P/S
7.19
P/B
0.07
P/Free Cash Flow
EPS
-28.73
Average EPS Est. Cur. Y
-0.7
EPS Next Y. (Est.)
-12.15
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-6336.27
Relative Volume
0.32
Return on Equity vs Sector %
-108.1
Return on Equity vs Industry %
-92.6
EPS 1 7Days Diff
0.1
EPS 1 30Days Diff
0.06
EBIT Estimation
◆
CODX
Healthcare
$1.75
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
38.8
Range 1M
5.1%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
43.6%
EPS NY
42.1%
52W%
0.3%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+2471.4% upside
Upside
+2471.4%
Quality
26
Co-Diagnostics, Inc.Sector: Healthcare
Industry: Medical Devices
Employees: 132
Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is based in Salt Lake City, Utah.
CODX
Latest News
—
Caricamento notizie per CODX…
stock quote shares CODX – Co-Diagnostics, Inc. Stock Price stock today
news today CODX – Co-Diagnostics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch CODX – Co-Diagnostics, Inc. yahoo finance google finance
stock history CODX – Co-Diagnostics, Inc. invest stock market
stock prices CODX premarket after hours
ticker CODX fair value insiders trading